Parkinson’s disease remains a formidable problem, with approximately 60,000 Americans diagnosed with it each year. In the UK, there are currently around 127,000 individuals living with the disease. Yet few people worldwide understand why some people develop the condition while others don’t. Because of this, researchers are constantly trying new approaches to treat Parkinson’s, which has yet to be reversed or cured. One of the latest techniques added to the arsenal of effective treatments focuses on a drug that has already been approved for use — a cholesterol-lowering treatment called Simvastatin.
